F Ramezani Ali Akbari1,2, M Badavi1,2,3, M Dianat1,2, S A Mard1,2, A Ahangarpour1,2,4. 1. Ahvaz Jundishapur University of Medical Sciences, Ahvaz Physiology Research Center, Ahvaz, Iran. 2. Ahvaz Jundishapur University of Medical Sciences, School of Medicine, Dept. of Physiology, Ahvaz, Iran. 3. Ahvaz Jundishapur University of Medical Sciences, Atherosclerosis Research Center, Ahvaz, Iran. 4. Ahvaz Jundishapur University of Medical Sciences, Diabetes Research Center, Ahvaz, Iran.
Abstract
CONTEXT: Endothelial dysfunction and diabetic cardiomyopathy are critical complications of diabetes. Gallic acid (GA) plays a significant role in cardiovascular disorders resulted from diabetes. In addition, increased plasma miR-24, miR-126 associated with endothelial dysfunction. AIM: The current study was designed to assess the effects of GA on plasma miR-24, miR-126 levels in the diabetic rats. ANIMALS AND METHODS: Adult male Sprague-Dawley rats were divided into three groups (n=8): control (C), diabetic (D) and diabetic group treated with GA (D+G, 25 mg/kg, by gavage) for eight weeks. The blood glucose level, body weight, lipid profile, blood pressure, plasma miR-24 and miR-126 levels, antioxidant and inflammatory biomarkers were measured. RESULTS: The plasma levels of miR-24, miR-126, body weight, high-density lipoprotein cholesterol (HDL-c), total anti-oxidant capacity (TAC) and the systolic blood pressure significantly reduced and blood glucose, total cholesterol (TC), triglycerides (TG), very low-density lipoprotein cholesterol (VLDL-c), malondialdehyde (MDA), interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α) and low-density lipoprotein cholesterol (LDL-c) significantly elevated among the diabetic rats compared with the control group. However, GA restored body weight, blood pressure, TC, TG, VLDL-c, TNF-α, miR-126, blood glucose, HDL-c, MDA, TAC, miR-24 and IL-6 among the GA treated rats compared with the diabetic group. CONCLUSION: GA improves inflammation, oxidative stress and hypotension result from diabetes. These protective effects are probably mediated via increasing plasma miR-24 and miR-126 levels.
CONTEXT: Endothelial dysfunction and diabetic cardiomyopathy are critical complications of diabetes. Gallic acid (GA) plays a significant role in cardiovascular disorders resulted from diabetes. In addition, increased plasma miR-24, miR-126 associated with endothelial dysfunction. AIM: The current study was designed to assess the effects of GA on plasma miR-24, miR-126 levels in the diabetic rats. ANIMALS AND METHODS: Adult male Sprague-Dawley rats were divided into three groups (n=8): control (C), diabetic (D) and diabetic group treated with GA (D+G, 25 mg/kg, by gavage) for eight weeks. The blood glucose level, body weight, lipid profile, blood pressure, plasma miR-24 and miR-126 levels, antioxidant and inflammatory biomarkers were measured. RESULTS: The plasma levels of miR-24, miR-126, body weight, high-density lipoprotein cholesterol (HDL-c), total anti-oxidant capacity (TAC) and the systolic blood pressure significantly reduced and blood glucose, total cholesterol (TC), triglycerides (TG), very low-density lipoprotein cholesterol (VLDL-c), malondialdehyde (MDA), interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α) and low-density lipoprotein cholesterol (LDL-c) significantly elevated among the diabetic rats compared with the control group. However, GA restored body weight, blood pressure, TC, TG, VLDL-c, TNF-α, miR-126, blood glucose, HDL-c, MDA, TAC, miR-24 and IL-6 among the GA treated rats compared with the diabetic group. CONCLUSION: GA improves inflammation, oxidative stress and hypotension result from diabetes. These protective effects are probably mediated via increasing plasma miR-24 and miR-126 levels.
Authors: Sebastian Albinsson; Yajaira Suarez; Athanasia Skoura; Stefan Offermanns; Joseph M Miano; William C Sessa Journal: Arterioscler Thromb Vasc Biol Date: 2010-04-08 Impact factor: 8.311
Authors: Antonio Ceriello; Lisa Quagliaro; Michele D'Amico; Clara Di Filippo; Raffaele Marfella; Francesco Nappo; Liberato Berrino; Francesco Rossi; Dario Giugliano Journal: Diabetes Date: 2002-04 Impact factor: 9.461
Authors: Anna Zampetaki; Stefan Kiechl; Ignat Drozdov; Peter Willeit; Ursula Mayr; Marianna Prokopi; Agnes Mayr; Siegfried Weger; Friedrich Oberhollenzer; Enzo Bonora; Ajay Shah; Johann Willeit; Manuel Mayr Journal: Circ Res Date: 2010-07-22 Impact factor: 17.367
Authors: Christina M Sorensen; Jie Ding; Qibin Zhang; Thierry Alquier; Rui Zhao; Patricia W Mueller; Richard D Smith; Thomas O Metz Journal: Clin Biochem Date: 2010-05-16 Impact factor: 3.281
Authors: Jason E Fish; Massimo M Santoro; Sarah U Morton; Sangho Yu; Ru-Fang Yeh; Joshua D Wythe; Kathryn N Ivey; Benoit G Bruneau; Didier Y R Stainier; Deepak Srivastava Journal: Dev Cell Date: 2008-08 Impact factor: 12.270
Authors: Sebastian Albinsson; Athanasia Skoura; Jun Yu; Annarita DiLorenzo; Carlos Fernández-Hernando; Stefan Offermanns; Joseph M Miano; William C Sessa Journal: PLoS One Date: 2011-04-22 Impact factor: 3.240